Clinical Trials Sponsored by ISA+Pharmaceuticals

Total 22461 results

Taro Pharmaceuticals USA

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Atopic Dermatitis

United States
Taro Pharmaceuticals USA

Completed

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

Scalp Psoriasis
Taro Pharmaceuticals USA

Completed

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Plaque Psoriasis
Taro Pharmaceuticals USA

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Efficacy Study in Patients With Acne Vulgaris.

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail

Onychomycosis
Taro Pharmaceuticals USA

Completed

Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

Tinea Pedis
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Teva Pharmaceuticals USA

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
Taro Pharmaceuticals USA

Completed

Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice

Pediculosis

United States
Taro Pharmaceuticals USA

Completed

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Bioequivalence Study of Two Imiquimod Cream 5%

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Belize
Teva Pharmaceuticals USA

Completed

Anastrozole 1 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Anastrozole 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 80 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Cilostazol 50 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Non-Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Finasteride 5 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.

Healthy

United States

3

Subscribe